Nadav Kidron

But if you had a nice run, so at least they took off the investment they had.

And if it succeeds, so they can have a huge upside.

Or they lose it all.

Or they lose it all.

This is a high-risk area.

But you see today many, many, many companies who are doing their R&D, who are public, and they have values from $5 million to several billion dollars, pre-revenue companies.

So my background is I'm a lawyer.

I have an MBA.

I'm into the business side.

My mother, since I was born, she was a scientist that worked specifically on insulin and getting an alternative way to deliver insulin into the liver.

And about 2006, she came to me and she said, listen, son, we have a breakthrough.

We have a technology that can allow us to take insulin and potentially other drugs as well, other peptides as well.

And we want to take it forward.

The medical center doesn't have the funds to take it forward.

And it can help many people.

Do you want to get involved?

And I said, it can help many people.

It also has a huge financial upside.

And basically I went to the medical center.

I worked with the tech transfer to take the IP, the technology out of that, out of the medical center.